Chemed [CHE] vs Option Care Health [OPCH] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Chemed wins in 13 metrics, Option Care Health wins in 6 metrics, with 0 ties. Chemed appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Chemed Option Care Health Better
P/E Ratio (TTM) 22.42 21.58 Option Care Health
Price-to-Book Ratio 5.28 3.24 Option Care Health
Debt-to-Equity Ratio 12.15 90.35 Chemed
PEG Ratio -0.96 21.58 Chemed
EV/EBITDA 14.34 13.59 Option Care Health
Profit Margin (TTM) 11.56% 3.93% Chemed
Operating Margin (TTM) 11.00% 5.84% Chemed
EBITDA Margin (TTM) 11.00% 5.84% Chemed
Return on Equity 24.14% 15.25% Chemed
Return on Assets (TTM) 13.56% 6.20% Chemed
Free Cash Flow (TTM) $367.97M $287.79M Chemed
Dividend Yield 0.18% N/A N/A
1-Year Return -26.86% -9.40% Option Care Health
Price-to-Sales Ratio (TTM) 2.53 0.82 Option Care Health
Enterprise Value $6.23B $5.44B Chemed
EV/Revenue Ratio 2.48 1.01 Option Care Health
Gross Profit Margin (TTM) 29.85% 19.00% Chemed
Revenue per Share (TTM) $170 $32 Chemed
Earnings per Share (Diluted) $19.45 $1.26 Chemed
Beta (Stock Volatility) 0.43 0.89 Chemed
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Chemed vs Option Care Health Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Chemed-0.32%-2.40%-6.77%-8.52%-26.64%-18.29%
Option Care Health-0.34%-3.74%-8.38%-12.53%-20.14%18.06%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Chemed-26.86%-0.25%-13.34%227.74%644.32%952.22%
Option Care Health-9.40%-18.44%90.75%298.81%14.73%3.08%

News Based Sentiment: Chemed vs Option Care Health

Chemed

News based Sentiment: MIXED

Chemed experienced a month of mixed signals, with a recent earnings miss and insider selling offset by strategic initiatives and a commitment to shareholder returns. The upcoming Q3 earnings release is a critical catalyst for the stock's future, making this a significant month for investors to assess the company's direction.

View Chemed News Sentiment Analysis

Option Care Health

News based Sentiment: MIXED

Option Care Health demonstrated strong financial performance in October with an earnings beat and revised guidance, but a 'Hold' rating from TD Cowen and ongoing contract negotiations with Janssen create a mixed investment picture. The debt refinancing provides financial flexibility, but near-term catalysts appear limited.

View Option Care Health News Sentiment Analysis

Performance & Financial Health Analysis: Chemed vs Option Care Health

MetricCHEOPCH
Market Information
Market Cap i$6.35B$4.47B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i198,9802,007,746
90 Day Avg. Volume i201,8871,946,452
Last Close$430.02$26.71
52 Week Range$408.42 - $623.61$21.39 - $35.53
% from 52W High-31.04%-24.82%
All-Time High$654.62 (Mar 11, 2024)$91.80 (Apr 22, 2002)
% from All-Time High-34.31%-70.90%
Growth Metrics
Quarterly Revenue Growth0.04%0.15%
Quarterly Earnings Growth-0.26%-0.05%
Financial Health
Profit Margin (TTM) i0.12%0.04%
Operating Margin (TTM) i0.11%0.06%
Return on Equity (TTM) i0.24%0.15%
Debt to Equity (MRQ) i12.1590.35
Cash & Liquidity
Book Value per Share (MRQ)$82.56$8.38
Cash per Share (MRQ)$17.22$1.27
Operating Cash Flow (TTM) i$426.78M$279.64M
Levered Free Cash Flow (TTM) i$285.06M$194.12M
Dividends
Last 12-Month Dividend Yield i0.18%N/A
Last 12-Month Dividend i$1.00N/A

Valuation & Enterprise Metrics Analysis: Chemed vs Option Care Health

MetricCHEOPCH
Price Ratios
P/E Ratio (TTM) i22.4221.58
Forward P/E i17.5221.58
PEG Ratio i-0.9621.58
Price to Sales (TTM) i2.530.82
Price to Book (MRQ) i5.283.24
Market Capitalization
Market Capitalization i$6.35B$4.47B
Enterprise Value i$6.23B$5.44B
Enterprise Value Metrics
Enterprise to Revenue i2.481.01
Enterprise to EBITDA i14.3413.59
Risk & Other Metrics
Beta i0.430.89
Book Value per Share (MRQ) i$82.56$8.38

Financial Statements Comparison: Chemed vs Option Care Health

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)CHEOPCH
Revenue/Sales i$646.94M$1.33B
Cost of Goods Sold i$430.53M$1.07B
Gross Profit i$216.41M$263.05M
Research & Development iN/AN/A
Operating Income (EBIT) i$94.76M$79.19M
EBITDA i$112.02M$93.16M
Pre-Tax Income i$95.67M$63.56M
Income Tax i$23.92M$16.81M
Net Income (Profit) i$71.76M$46.74M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)CHEOPCH
Cash & Equivalents i$173.88M$198.82M
Total Current Assets i$502.39M$1.18B
Total Current Liabilities i$290.56M$773.62M
Long-Term Debt i$102.08M$1.20B
Total Shareholders Equity i$1.18B$1.36B
Retained Earnings i$2.79B$766.60M
Property, Plant & Equipment i$724.13M$134.76M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)CHEOPCH
Operating Cash Flow i$34.75M$-46.97M
Capital Expenditures i$112,000$-9.37M
Free Cash Flow i$19.46M$-16.59M
Debt Repayment iN/A$-1.63M
Common Stock Repurchase i$-33.22M$-100.22M

Short Interest & Institutional Ownership Analysis

MetricCHEOPCH
Shares Short i387,6715.55M
Short Ratio i2.172.93
Short % of Float i0.03%0.05%
Average Daily Volume (10 Day) i198,9802,007,746
Average Daily Volume (90 Day) i201,8871,946,452
Shares Outstanding i14.56M166.26M
Float Shares i14.29M152.85M
% Held by Insiders i0.02%0.01%
% Held by Institutions i0.98%1.02%

Dividend Analysis & Yield Comparison: Chemed vs Option Care Health

MetricCHEOPCH
Last 12-Month Dividend i$1.00N/A
Last 12-Month Dividend Yield i0.18%N/A
3-Year Avg Annual Dividend i$1.37N/A
3-Year Avg Dividend Yield i0.08%N/A
3-Year Total Dividends i$4.10N/A
Ex-Dividend DateNov 18, 2024N/A